Jagran Josh Logo

WHO approved the use of experimental drug ZMapp to fight Ebola Virus

Aug 13, 2014 17:03 IST

The World Health Organisation (WHO) on 12 August 2014 sanctioned the use of experimental drug ZMapp to fight against Ebola as the death toll increased.

The declaration of WHO came after a US company Mapp Biopharmaceutical supplied ZMapp to two US doctors Kent Brantly and Nancy Writebo who got affected with the Ebola disease while treating Ebola affected patients in Liberia. It showed some positive effects in saving the lives of Ebola-affected people.

After considering all the aspects, the panel of WHO reached a consensus that the experimental drugs should be used with all transparency including  aspects of care, freedom of choice, confidentiality, respect for the person and preservation of dignity. Doctors would not use ZMapp without permission of the patients.  

ZMapp
The current outbreak of Ebola is described as the worst since the discovery of Ebola Virus. There is no available cure for Ebola currently. Mapp Biopharmaceutical in the first week of August 2014, made available the drug ZMapp to two US doctors Kent Brantly and Nancy Writebo who got affected with the Ebola disease while treating Ebola affected patients in Liberia and then to Spain Government for treating Ebola-affected patient.

The drug uses a new method of passive immunization to treat Ebola infection by inserting genetically altered Ebola protein into tobacco leaves. However, ZMapp has been tested only on monkeys so far and it was to be tested on healthy human volunteers in 2015. The sudden outbreak of Ebola speeded up the process.

If you have any Question/Point on the above information, please ask/discuss it in the Current Affairs Group

Is this article important for exams ? Yes188 People Agreed
Read more Current Affairs on: experimental drug , ZMapp , World Health Organisation , WHO , Ebola

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

Newsletter Signup
Follow us on
This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK